Fundraising Fox

Gilgamesh Pharma

New York, US · Founded 2025 · Delaware corporation · 35 employees on LinkedIn · 1 known investors

Biotech

Founders & leadership

Gilgamesh Pharma was founded in 2025 by Andrew Kruegel and Jonathan Sporn.

AK
Andrew KruegelCo-founder
JS
Jonathan SpornCo-founder

Board

ZHZia Huque
Zia HuqueinBoard directorGeneral Partner at Prime Movers Lab
AKAmy Kruse
Amy KruseinBoard directorVenture Partner at Prime Movers Lab
RB
Robert BermanBoard director
PS
Phil SkolnickBoard director

Investors · 1

Prime Movers LabreportedJackson · $2M – $30Mvia Zia Huque · board

Reported raises · per SEC filings

Form D private placements

$68.3M disclosed across 3 of 4 rounds · 2026

▶$2.3MraisedMar 2026 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Amy KruseDirector
  • Jonathan SpornExecutive Officer, Director
  • Phil SkolnickDirector
  • Zia HuqueDirector
  • Robert BermanDirector
  • Andrew KruegelExecutive Officer, Director
Offering amount
$15M
Amount sold
$2.3M
Minimum investment
$50K
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$60MraisedMar 2026 · 40 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Amy KruseDirector
  • Zia HuqueDirector
  • Robert BermanDirector
  • Phil SkolnickDirector
  • Jonathan SpornExecutive Officer, Director
  • Andrew KruegelExecutive Officer, Director
Offering amount
$60M
Amount sold
$60M
Minimum investment
$50K
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.4MofferedFeb 2026 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Phil SkolnickDirector
  • Robert BermanDirector
  • Zia HuqueDirector
  • Amy KruseDirector
  • Andrew KruegelExecutive Officer, Director
  • Jonathan SpornExecutive Officer, Director
Offering amount
$4.4M
Minimum investment
$27
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedFeb 2026 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew KruegelExecutive Officer, Director
  • Zia HuqueDirector
  • Robert BermanDirector
  • Phil SkolnickDirector
  • Jonathan SpornExecutive Officer, Director
  • Amy KruseDirector
Offering amount
$6.1M
Amount sold
$6.1M
Minimum investment
$27.6K
First sale
Jan 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Gilgamesh Pharma went on to found or lead other companies.

Dakin SlossInvestorFounded Tachyus +1Andrew KruegelChief Scientific OfficerFounded Gilgamesh Pharmaceuticals

In the news

Sell or Invest in Gilgamesh Pharma Stock Pre-IPOnasdaqprivatemarket.com · Apr 2026Gilgamesh Pharma Raises $60M Series A Fundingallsci.com · Mar 2026Gilgamesh’s psychedelics pipeline gets $60M backing after AbbVie dealendpoints.news · Mar 2026Gilgamesh Pharma Raises $60 Million Series A to Advance Post-Acquisition Neuropsychiatric Pipeline - TipRanks.comtipranks.com · Mar 2026Gilgamesh Pharma Closes Oversubscribed $60 Million Series A to Develop Next Generation Neuropsychiatric Therapiesfinance.yahoo.com · Mar 2026Gilgamesh Pharma Announces Positive Topline Phase 2a Results for Blixeprodil (GM-1020) in Major Depressive Disorder - BioSpacebiospace.com · Jan 2026

Frequently asked questions

Who founded Gilgamesh Pharma?
Gilgamesh Pharma was founded by Andrew Kruegel, Jonathan Sporn in 2025.
Who are Gilgamesh Pharma's investors?
Gilgamesh Pharma's investors include Prime Movers Lab.
How much funding has Gilgamesh Pharma raised?
Gilgamesh Pharma has disclosed $68.3M raised across 3 of its 4 known rounds.
Where is Gilgamesh Pharma headquartered?
Gilgamesh Pharma is headquartered in New York, US.